Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/24 16:23 | 8/29/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Niklason Laura E | NC | DO | P,CEO,Di | 3 | P | 38 | 6.76 | 0 | 6 | 0 | 8,088 | D | ||||||||||||||
9/3/24 16:17 | 8/29/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Dougan Brady W | NC | D | 3 | P | 38 | 6.76 | 0 | 6 | 0 | 8,088 | I | |||||||||||||||
8/15/24 16:08 | 8/15/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Constantino Michael T. | NC | D | 1 | P | 19 | 6.29 | 0 | 3 | 34 | 12 | D | |||||||||||||||
5/21/24 16:08 | 5/20/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Wallace Max N. | NC | D | 1 | P | 50 | 6.25 | 0 | 8 | 14 | 65 | I | |||||||||||||||
5/15/24 19:24 | 5/15/24 | HUMA | Health | BioPrd | Biological Products, (No Diag | Binder Gordon M | NC | D | 1 | P | 668 | 6.68 | 0 | 100 | 91 | 210 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |